
FDA looking to make vapes less addictive as agency head claims 85% of those sold are ‘illegal'
Vapes or e-cigarettes are the most commonly used tobacco product among American youths, and there is growing concern about addiction.
The agency has formally recommended that the Drug Enforcement Administration (DEA) classify certain 7-hydroxymitragynine (7-OH) products under the Controlled Substances Act.
Speaking to Newsmax, FDA Commissioner Marty Makary said there is a widespread problem with illicit vaping products.
'First of all, 85 percent of vaping products sold at your local vape shop are illegal,' he told Rob Schmitt Tonight. 'These are products that are even banned in China, where they come from. They've got these cutesy, fruity flavours or even a video game [that is] part of the vape device designed to addict kids.'
Makary went on to condemn these products as 'predatory' and warned of a growing 'epidemic,' noting that 'at some high schools, a quarter of the kids are using these vaping products regularly. So, we've got an epidemic we've got to address,' he said.
The substance 7-OH, described by Makary as an opioid, is a derivative of kratom, a South Asian tree. While kratom leaves can produce stimulant effects at low doses and sedative effects at higher doses, the DEA warns they can also lead to psychotic symptoms and both psychological and physiological dependence.
Makary issued a stark warning to parents: 'You can walk down to many of these vape stores or convenience stores or gas stations and buy an opioid today.'
He added: 'Parents need to know about this. And we recommended the DEA starts to schedule this as a controlled substance. And that's something that's inside of these vapes.'
Makary clarified the FDA's focus, explaining: ' Kratom has a trace amount of 7-OH. We're not focused on that. We're focused on the synthetic concentrated byproduct.'
According to data from the Centers for Disease Control and Prevention, the use of e-cigarettes was the most commonly used tobacco product among middle and high school students in the United States in 2024.
A total of 1.63 million (5.9 percent) students currently use them, including 410,000 (3.5 percent) middle school pupils and 1.21 million (7.8 percent) high school students.
Of these, 87.6 percent reported using flavoured e-cigarettes, with disposable e-cigarettes the most popular choice at 55.6 percent, followed by prefilled or refillable pods (15.6 percent) and tank or mod systems (7 percent).
According to Johns Hopkins Medicine, evidence shows that vaping is less harmful than smoking, as it exposes users to fewer toxins and at lower levels than smoking cigarettes.
However, vapes are just as addictive as traditional cigarettes, as many users get even more nicotine than they would from a combustible tobacco product because users can buy extra-strength cartridges or increase the e-cigarette's voltage to get a greater hit of the substance.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
6 minutes ago
- The Independent
RFK Jr. pulls $500 million in funding for vaccine development
The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like COVID-19 and the flu. Robert F. Kennedy Jr., the health secretary and a longtime vaccine critic, announced in a statement Tuesday that $500 million worth of vaccine development projects, all using mRNA technology, will be halted. The projects — 22 of them — are being led by some of the nation's leading pharmaceutical companies like Pfizer and Moderna to prevent flu, COVID-19 and H5N1 infections. The mRNA vaccines are credited with slowing the 2020 coronavirus pandemic. Kennedy said in the Tuesday statement that he wants the health department to move away from mRNA vaccines, calling on the department to start 'investing in better solutions.' He provided no details on what those technologies might be.


Daily Mail
7 minutes ago
- Daily Mail
CHRISTOPHER STEVENS reviews Do You Have ADHD?: 'Do you fidget and get distracted by noise? Maybe you've got ADHD too'
Nobody wants to be schizophrenic these days. Why would they? It's a horrible mental illness, one commonly treated with anti-psychotic drugs. Believe it or not, it was frightfully fashionable in the 1960s. Dinner party guests clamoured to tell each other, 'Well, I don't know, I suppose I must be a little bit schizo!' Quack psychiatrists made their names diagnosing actors and pop stars with the condition. The leading light was Scottish doctor and bestselling writer R.D. Laing, who treated Sean Connery by dosing him with LSD. These days, the most talked about diagnosis is Attention Deficit Hyperactivity Disorder [ADHD]. Not a day passes without a celebrity or online influencer declaring proudly that they have ADHD — with the unspoken implication that this excuses all their failings and confirms what they've always felt... that they are special. Follow the guidelines laid down in Do You Have ADHD?, and we can all be special. It's easy. Before the first ad break, presenter Dr Karan Rajan urged us to download a questionnaire from the World Health Organisation [WHO], designed to identify key traits. The questions have been set by three American professors at Harvard and the New York University medical schools, and given an impressive title: the Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist. Naturally, I paused the show and filled in the quiz immediately. This, I feel, proves impressively how limited my own attention span is. Do I fidget, asked the WHO? Do I forget appointments? Do I make careless mistakes when engaged on boring tasks? Do I get distracted by noise around me? Yes, all of the above. Now I can apply to join the eight-year NHS waiting list for an ADHD diagnosis, or take a shortcut and go private. Of course I'll go private! If I had the patience to wait eight years, I wouldn't have ADHD, would I? And, fortunately, there are lots of clinics willing to take my money, in exchange for an assessment. Dr Clare Bailey Mosley, the widow of much-loved Daily Mail writer Michael Mosley, took the test, partly because she suspected her late husband had ADHD himself. In her case, the outcome seemed eminently sensible: she exhibited some of the typical traits but could not be said to have ADHD because her daily life wasn't impaired. Clearly, the same applied to Michael. No doubt, he had a butterfly mind and needed a deadline if he was to get a job finished, but that's what made him a successful journalist. The rest of this documentary was mostly shallow and trivial. Asked what indicators he looks for in children with ADHD, Professor Stephen Scott of King's College London said, 'First of all, if you just watch them in the school playground, are they running around more than other kids?' 'Running around' is now a childhood medical condition. Nurse!


The Independent
36 minutes ago
- The Independent
Pfizer CEO says pharmaceutical companies want to work with Trump to make medicine more affordable
Pfizer CEO Albert Bourla announced that major pharmaceutical companies are ready to work with the Trump administration to make medicines more affordable and directly available to consumers. This move comes after Trump demanded that 17 drugmakers expand direct-to-consumer options and lower prices to match those in other industrialized countries, threatening to use 'every tool' if they did not comply. Pfizer and Bristol Myers Squibb have already revealed plans to offer their blood thinner Eliquis at a lower price online, building on Pfizer's existing direct-to-consumer telehealth and prescription services. Other companies, such as Eli Lilly and Novo Nordisk, are also exploring direct access for their obesity drugs, aiming to bypass pharmacy benefit managers. Despite potential sector-specific tariffs on pharmaceutical imports, which could escalate to 250 percent, Pfizer expects to meet its financial forecasts, though experts have refuted Trump's claims of significant drug price reductions.